Viewing Study NCT00353457


Ignite Creation Date: 2025-12-24 @ 6:34 PM
Ignite Modification Date: 2026-01-29 @ 11:59 AM
Study NCT ID: NCT00353457
Status: TERMINATED
Last Update Posted: 2020-04-09
First Post: 2006-07-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal Adenocarcinoma
Sponsor: Abramson Cancer Center at Penn Medicine
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cetuximab View
None Adjuvant therapy View
None Rectal cancer View
None Capecitabine View
None Oxaliplatin View
None Erbitux View